Prescription drug · ANDA
Methocarbamol NDC 86211-114
Methocarbamol 100 mg/mL · Injection · Intramuscular, Intravenous, Intravenous · JVET PHARMACEUTICALS LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 86211-114-10 | 8621101141086211011410 | 10 VIAL in 1 CARTON (86211-114-10) / 10 mL in 1 VIAL (86211-114-01)Marketed from May 22, 2026 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Methocarbamol
- Generic name (nonproprietary)
- methocarbamol
- Active ingredients
- Methocarbamol — 100 mg/mL
- Dosage form
- Injection
- Route
- Intramuscular, Intravenous, Intravenous
- Labeler
- JVET PHARMACEUTICALS LLCNDC labeler code 86211
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 211504
- Marketing start
- Listing expires
- Other FDA classes
- Centrally-mediated Muscle Relaxation (Physiologic effect)
- Identifiers
- Product ID 86211-114_f0d0d131-38fa-4644-bfc9-d027b3511149SPL ID f0d0d131-38fa-4644-bfc9-d027b3511149SPL set ID d9e4748f-11c5-4d87-b260-1be94febe806RxCUI 238175UNII 125OD7737XUPC 0386211114102
- Pharmacologic class
- Muscle Relaxant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N486211011410followed by a unit qualifier and the quantityPackage 86211-0114-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE The injectable form of methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.
Excerpt only. Read the full label for complete information.
About NDC 86211-114
- What is NDC 86211-114?
- 86211-114 is the product NDC for Methocarbamol, Methocarbamol 100 mg/mL injection, listed with the FDA by JVET PHARMACEUTICALS LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Methocarbamol.
- What is the active ingredient?
- Methocarbamol.
- Who is the labeler?
- JVET PHARMACEUTICALS LLC, NDC labeler code 86211. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Methocarbamol?
- 200 other product NDCs are listed under this name. See all Methocarbamol NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Methocarbamol products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | American Health Packaging | 60687-945 | 60687-0945-01 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | American Health Packaging | 60687-956 | 60687-0956-01 |
| Methocarbamol | Methocarbamol 500 mg/1 | TabletOral | REGIMED MEDICAL | 25685-240 | 25685-0240-10 |
| Methocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | 60760-874 | 60760-0874-90 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 750 mg/1 | Tablet, CoatedOral | Coupler LLC | 67046-0340 | 67046-0340-03 |
| Methocarbamol | Methocarbamol 500 mg/1 | TabletOral | Coupler LLC | 67046-1177 | 67046-1177-03 |
| Methocarbamol | Methocarbamol 500 mg/1 | Tablet, Film coatedOral | Medcore LLC | 82461-722 | 82461-0722-90 |
| Methocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | Medcore LLC | 82461-723 | 82461-0723-90 |
| Methocarbamolmethocarbamol tablets | Methocarbamol 500 mg/1 | Tablet, CoatedOral | Unit Dose Solutions, Inc. | 87441-086 | 87441-0086-01 |
| Methocarbamol | Methocarbamol 750 mg/1 | Tablet, Film coatedOral | St. Mary's Medical Park Pharmacy | 60760-875 | 60760-0875-2860760-0875-4060760-0875-90 |
Other NDCs under ANDA 211504
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Methocarbamol | Methocarbamol 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | Sagent Pharmaceuticals | 25021-689 |
| Methocarbamol | Methocarbamol 100 mg/mL | InjectionIntramuscular, Intravenous | Dr.Reddys Laboratories Inc., | 43598-839 |
| Methocarbamol | Methocarbamol 100 mg/mL | InjectionIntramuscular, Intravenous | Gland Pharma Limited | 68083-317 |
| Methocarbamol | Methocarbamol 100 mg/mL | Injection, SolutionIntramuscular, Intravenous | Meitheal Pharmaceuticals Inc. | 71288-716 |